(GALT) Galectin Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Galectin Therapeutics | (GALT) share price targets
Complete technical analysis of Galectin Therapeutics (GALT) by charts plus indicators, forecast predictions and share price targets for Galectin Therapeutics (GALT)
Galectin Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-11-07 View latest technical analysis
10 day averaged volume of Galectin Therapeutics is 137720
| Date | Daily Closing Price | Open | High | Low | Volume |
| 07 Thu Nov 2024 | 2.84 | 2.78 | 2.89 | 2.76 | 0.86 times |
| 06 Wed Nov 2024 | 2.81 | 2.80 | 2.85 | 2.67 | 1.947 times |
| 05 Tue Nov 2024 | 2.61 | 2.55 | 2.62 | 2.52 | 0.725 times |
| 04 Mon Nov 2024 | 2.53 | 2.46 | 2.60 | 2.46 | 0.78 times |
| 01 Fri Nov 2024 | 2.50 | 2.51 | 2.58 | 2.45 | 0.799 times |
| 31 Thu Oct 2024 | 2.47 | 2.50 | 2.57 | 2.45 | 0.834 times |
| 30 Wed Oct 2024 | 2.52 | 2.55 | 2.65 | 2.51 | 0.948 times |
| 29 Tue Oct 2024 | 2.55 | 2.49 | 2.64 | 2.49 | 0.958 times |
| 28 Mon Oct 2024 | 2.49 | 2.56 | 2.60 | 2.49 | 1.321 times |
| 25 Fri Oct 2024 | 2.51 | 2.57 | 2.59 | 2.51 | 0.802 times |
Although my analysis for stock is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 2.8, for a target of 2.7 or 2.61
Share price targets for Galectin Therapeutics (GALT)
| Target Type | Value |
| Downside Target | 1.98 |
| Downside Target | 2.40 |
| Downside Target | 2.45 |
| Downside Target | 2.51 |
| Downside Target | 2.59 |
| Downside Target | 2.65 |
| Downside Target | 2.80 |
| Upside Target | 2.89 |
| Upside Target | 2.92 |
| Upside Target | 2.97 |
| Upside Target | 2.98 |
| Upside Target | 3.16 |
Intraday share price targets for Galectin Therapeutics (GALT)
| Target Type | Value |
| Downside Intraday Target | 2.57 |
| Downside Intraday Target | 2.3 |
| Upside Intraday Target | 3 |
| Upside Intraday Target | 3.16 |
| Downside Intraday Target | 2.73 |
Weekly technical analysis of Galectin Therapeutics (GALT)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 07 Thu Nov 2024 | 2.84 | 2.46 | 2.89 | 2.46 | 0.887 times |
| 01 Fri Nov 2024 | 2.50 | 2.56 | 2.65 | 2.45 | 1.194 times |
| 25 Fri Oct 2024 | 2.51 | 2.70 | 2.70 | 2.51 | 0.866 times |
| 18 Fri Oct 2024 | 2.67 | 2.70 | 2.80 | 2.59 | 1.023 times |
| 11 Fri Oct 2024 | 2.70 | 2.85 | 2.89 | 2.52 | 0.874 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Galectin Therapeutics (GALT)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 07 Thu Nov 2024 | 2.84 | 2.51 | 2.89 | 2.45 | 0.23 times |
| 31 Thu Oct 2024 | 2.47 | 2.76 | 3.16 | 2.45 | 1.281 times |
| 30 Mon Sep 2024 | 2.75 | 2.64 | 2.98 | 2.40 | 0.826 times |
| 30 Fri Aug 2024 | 2.70 | 2.48 | 2.97 | 1.98 | 0.875 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Galectin Therapeutics (GALT)
Price action analysis of Galectin Therapeutics ( (GALT) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Galectin Therapeutics ( (GALT) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Galectin Therapeutics ( (GALT) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Galectin Therapeutics ( (GALT) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Galectin Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Galectin Therapeutics in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Galectin Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Galectin Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Galectin Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.6 and Galectin Therapeutics (GALT) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Galectin Therapeutics (GALT) stock. Volume based technical analysis of Galectin Therapeutics (GALT) stock is negative.
Galectin Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Galectin Therapeutics ( (GALT) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Galectin Therapeutics ( (GALT) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Galectin Therapeutics ( (GALT) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Galectin Therapeutics ( (GALT) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Galectin Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Galectin Therapeutics in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Galectin Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Galectin Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Galectin Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.6 and Galectin Therapeutics (GALT) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Galectin Therapeutics (GALT) stock. Volume based technical analysis of Galectin Therapeutics (GALT) stock is negative.
Galectin Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.